On April 18, 2023, the FDA in their infinite wisdom “Authorized Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines”. In their own words, the FDA... ...amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19…
more »